Chemical defenses are widespread among animals, and the compounds involved may be either synthesized from nontoxic precursors or sequestered from an environmental source. Defensive sequestration has been studied extensively among invertebrates, but relatively few examples have been documented among vertebrates. Nonetheless, the number of described cases of defensive sequestration in tetrapod vertebrates has increased recently and includes diverse lineages of amphibians and reptiles (including birds). The best-known examples involve poison frogs, but other examples include natricine snakes that sequester toxins from amphibians and two genera of insectivorous birds. Commonalities among these diverse taxa include the combination of consuming toxic prey and exhibiting some form of passive defense, such as aposematism, mimicry, or presumptive death-feigning. Some species exhibit passive sequestration, in which dietary toxins simply require an extended period of time to clear from the tissues, whereas other taxa exhibit morphological or physiological specializations that enhance the uptake, storage, and/or delivery of exogenous toxins. It remains uncertain whether any sequestered toxins of tetrapods bioaccumulate across multiple trophic levels, but multitrophic accumulation seems especially likely in cases involving consumption of phytophagous or mycophagous invertebrates and perhaps consumption of poison frogs by snakes. We predict that additional examples of defensive toxin sequestration in amphibians and reptiles will be revealed by collaborations between field biologists and natural product chemists. Candidates for future investigation include specialized predators on mites, social insects, slugs, and toxic amphibians. Comprehensive studies of the ecological, evolutionary, behavioral, and regulatory aspects of sequestration will require teams of ecologists, systematists, ethologists, physiologists, molecular biologists, and chemists. The widespread occurrence of sequestered defenses has important implications for the ecology, evolution, and conservation of amphibians and reptiles.

Significance: Animals protected by sequestered toxins must employ an alternative source of defensive chemicals when a shift in diet evolves. Snakes of the genus Rhabdophis possess defensive glands that store powerful defensive toxins known as bufadienolides. The ancestral prey of Rhabdophis consists of anuran amphibians, including toads (Bufonidae) that are the source of sequestered bufadienolides. However, members of a derived clade of Rhabdophis consume nontoxic earthworms as their primary prey, yet their integumentary glands still contain bufadienolides. We demonstrate that snakes in the worm-eating clade obtain their defensive toxins primarily by consuming larval fireflies. Our finding represents a remarkable evolutionary example in which a shift from vertebrate to nonvertebrate prey provides the same chemical class of sequestered defensive toxins.

Toads are chemically defended by bufadienolides, a class of cardiotonic steroids that exert toxic effects by binding to and disabling the Na⁺/K⁺-ATPases of cell membranes. Some predators, including a number of snakes, have evolved resistance to the toxic effects of bufadienolides and prey regularly on toads. Resistance in snakes to the acute effects of these toxins is conferred by at least two amino acid substitutions in the cardiotonic steroid binding pocket of the Na⁺/K⁺-ATPase. We surveyed 100 species of snakes from a broad phylogenetic range for the presence or absence of resistance-conferring mutations. We found that such mutations occur in a much wider range of taxa than previously believed. Although all sequenced species known to consume toads exhibited the resistance mutations, many of the species possessing the mutations do not feed on toads, much less specialize on that food source. This suggests that either there is little performance cost associated with these mutations or they provide an unknown benefit. Furthermore, the distribution of the mutation among major clades of advanced snakes suggests that the origin of the mutation reflects evolutionary retention more than dietary constraint.

Toads are defended chemically by bufadienolides, a class of cardiotonic steroids lethal to most predators. Bufadienolides bind toNa⁺,K⁺‐ATPases, inhibiting the ability of those cellular pumps to transport ions. In cardiocytes, this inhibition causes arrhythmia and increased contractile strength, which, if prolonged, lead to death. However, several snakes are resistant to bufadienolides and consume toads with no apparent ill effects. Adrenal glands produce hormones that function in the maintenance ofNa⁺,K⁺‐ATPases, and may therefore play an important role in countering the negative effects of bufadienolides. We hypothesized that bufophagous (toad‐eating) snakes have enlarged adrenal glands that contribute to the snakes' resistance to bufadienolides, and that sexual dimorphism in adrenal gland size is a general characteristic of bufophagous snakes. We compared phylogenetically independent pairs of taxa to investigate differences in adrenal morphology between bufophagous and nonbufophagous species. We also compared adrenal masses between males and females of bufophagous and nonbufophagous species to test whether sexual dimorphism in adrenal size reported for one species of bufophagous snakes represents a more widespread phenomenon. Our results demonstrate for the first time that the allometric relationship between adrenal mass and body size is significantly different between several bufophagous species and related nonbufophagous species; adrenal size differs between males and females in those bufophagous species, with males having larger adrenal glands, but no such dimorphism exists in related nonbufophagous species. These results demonstrate that parallel morphological responses have occurred repeatedly in bufophagous snakes and suggest that the adrenal glands play a role in mediating the negative effects of bufadienolide ingestion in bufophagous snakes.

This article captures a collective reflection on the successes and challenges we experienced when teaching physiology laboratories online during the COVID-19 pandemic. Physiology instructors from six institutions discussed their own efforts to redesign meaningful physiology laboratories that could be taught remotely, as the nation scrambled to respond to the sudden shift out of the classroom. Despite the complexity of this task, clear themes emerged as our courses transitioned to an online format in spring 2020 and were solidified in the fall of 2020. This article reflects on the history, features, benefits, and challenges of current laboratory teaching when applying a scientific teaching approach to facilitate the redesign process. We believe online networks like ours can facilitate information sharing, promote innovations, and provide support for instructors. The insights we gained through this collaboration will influence our thinking about the future of the physiology lab, whether online or in person.